Randomized controlled trial for endoscopic radiofrequency ablation in the treatment of chronic atrophic gastritl with intestinal metaplasia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025048

Enrollment

Unknown

Registered

2019-08-09

Start date

2017-06-01

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CAG

Interventions

1:Routine treatment

2:endoscopic radiofrequency ablation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Confirmed as chronic atrophic gastritis with intestinal metaplasia by gastroscopy and pathological biopsy; 2. Aged 18 to 80 years old; 3. Patients and their families required to undergo endoscopic radiofrequency ablation. 4. informed consent signed by the patient or his agent.

Exclusion criteria

Exclusion criteria: 1. Poor physical condition, unable to tolerate anesthesia and surgery, such as severe cardiopulmonary disease, coagulation dysfunction, liver and kidney dysfunction, etc.; 2. Gastrointestinal and other organ malignancies have been diagnosed.

Design outcomes

Primary

Measure	Time frame
Symptom improvement;	—

Contacts

Public ContactPan Wen

Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region (Hospital.C.T.)

lovehelen607@163.com+86 18011522930

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026